117 related articles for article (PubMed ID: 9413168)
41. N-(4-Hydroxyphenyl)retinamide is more potent than other phenylretinamides in inhibiting the growth of BRCA1-mutated breast cancer cells.
Simeone AM; Deng CX; Kelloff GJ; Steele VE; Johnson MM; Tari AM
Carcinogenesis; 2005 May; 26(5):1000-7. PubMed ID: 15695235
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of DMBA-initiated rat mammary tumour development by 1-O-hexyl-2,3,5-trimethylhydroquinone, phenylethyl isothiocyanate, and novel synthetic ascorbic acid derivatives.
Futakuchi M; Hirose M; Miki T; Tanaka H; Ozaki M; Shirai T
Eur J Cancer Prev; 1998 Apr; 7(2):153-9. PubMed ID: 9818778
[TBL] [Abstract][Full Text] [Related]
43. Low zinc intake suppressed N-methyl-N-nitrosourea-induced mammary tumorigenesis in Sprague-Dawley rats.
Lee S; Simpson M; Nimmo M; Xu Z
Carcinogenesis; 2004 Oct; 25(10):1879-85. PubMed ID: 15205360
[TBL] [Abstract][Full Text] [Related]
44. Suppression of cell proliferation and telomerase activity in 4-(hydroxyphenyl)retinamide-treated mammary tumors.
Bednarek A; Shilkaitis A; Green A; Lubet R; Kelloff G; Christov K; Aldaz CM
Carcinogenesis; 1999 May; 20(5):879-83. PubMed ID: 10334206
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of rat mammary carcinogenesis by an arotinoid without a polar end group (Ro 15-0778).
Bollag W; Hartmann HR
Eur J Cancer Clin Oncol; 1987 Feb; 23(2):131-5. PubMed ID: 2965015
[TBL] [Abstract][Full Text] [Related]
46. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
[TBL] [Abstract][Full Text] [Related]
47. Comparison of the therapeutic effects of a new arotinoid, Ro 40-8757, and all-trans- and 13-cis-retinoic acids on rat breast cancer.
Teelmann K; Tsukaguchi T; Klaus M; Eliason JF
Cancer Res; 1993 May; 53(10 Suppl):2319-25. PubMed ID: 8485719
[TBL] [Abstract][Full Text] [Related]
48. Lack of an effect of dietary retinoids in chemical carcinogenesis of the mouse mammary gland: inverse relationship between mammary tumor cell anaplasia and retinoid efficacy.
Welsch CW; DeHoog JV; Moon RC
Carcinogenesis; 1984 Oct; 5(10):1301-4. PubMed ID: 6237806
[TBL] [Abstract][Full Text] [Related]
49. A novel aromatase inhibitor, vorozole, shows antitumor activity and a decrease of tissue insulin-like growth factor-I level in 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Sugamata N; Koibuchi Y; Iino Y; Morishita Y
Int J Oncol; 1999 Feb; 14(2):259-63. PubMed ID: 9917500
[TBL] [Abstract][Full Text] [Related]
50. Study on potential effects of "902-MHz GSM-type Wireless Communication Signals" on DMBA-induced mammary tumours in Sprague-Dawley rats.
Hruby R; Neubauer G; Kuster N; Frauscher M
Mutat Res; 2008 Jan; 649(1-2):34-44. PubMed ID: 17981079
[TBL] [Abstract][Full Text] [Related]
51. Effects of a high olive oil diet on the clinical behavior and histopathological features of rat DMBA-induced mammary tumors compared with a high corn oil diet.
Solanas M; Hurtado A; Costa I; Moral R; Menéndez JA; Colomer R; Escrich E
Int J Oncol; 2002 Oct; 21(4):745-53. PubMed ID: 12239612
[TBL] [Abstract][Full Text] [Related]
52. Purple grape juice inhibits 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat mammary tumorigenesis and in vivo DMBA-DNA adduct formation.
Jung KJ; Wallig MA; Singletary KW
Cancer Lett; 2006 Feb; 233(2):279-88. PubMed ID: 15878797
[TBL] [Abstract][Full Text] [Related]
53. Efficacy of 9-cis-retinoic acid and N-(4-hydroxyphenyl) retinamide alone and in combination in mammary cancer prevention.
Cope MB; Steele VE; Lubet RA; Eto I; Juliana MM; Hill DL; Grubbs CJ
Oncol Rep; 2004 Feb; 11(2):465-9. PubMed ID: 14719085
[TBL] [Abstract][Full Text] [Related]
54. Lack of chemopreventive effects of alpha-eleostearic acid on 7,12-dimethylbenz[a]anthracene (DMBA) and 1,2-dimethylhydrazine (DMH)-induced mammary and colon carcinogenesis in female Sprague-Dawley rats.
Kitamura Y; Yamagishi M; Okazaki K; Umemura T; Imazawa T; Nishikawa A; Matsumoto W; Hirose M
Food Chem Toxicol; 2006 Feb; 44(2):271-7. PubMed ID: 16122863
[TBL] [Abstract][Full Text] [Related]
55. Therapeutic effect of N-(4-hydroxyphenyl)retinamide on N-methyl-N-nitrosourea-induced rat mammary cancer.
Dowlatshahi K; Mehta RG; Thomas CF; Dinger NM; Moon RC
Cancer Lett; 1989 Oct; 47(3):187-92. PubMed ID: 2534548
[TBL] [Abstract][Full Text] [Related]
56. The peptidomimetic, 1-adamantyl-substituted, and flex-het classes of retinoid-derived molecules: structure-activity relationships and retinoid receptor-independent anticancer activities.
Dawson MI; Fontana JA
Mini Rev Med Chem; 2010 Jun; 10(6):455-91. PubMed ID: 20370709
[TBL] [Abstract][Full Text] [Related]
57. [Effect of tamoxifen plus octreotide on DMBA-induced mammary tumors in rats].
Zeng XZ; Yao ZX
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):28-32. PubMed ID: 15808071
[TBL] [Abstract][Full Text] [Related]
58. LAS, a novel selective estrogen receptor modulator with chemopreventive and therapeutic activity in the N-nitroso-N-methylurea-induced rat mammary tumor model.
Cohen LA; Pittman B; Wang CX; Aliaga C; Yu L; Moyer JD
Cancer Res; 2001 Dec; 61(24):8683-8. PubMed ID: 11751385
[TBL] [Abstract][Full Text] [Related]
59. Diets containing whey proteins or soy protein isolate protect against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in female rats.
Hakkak R; Korourian S; Shelnutt SR; Lensing S; Ronis MJ; Badger TM
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):113-7. PubMed ID: 10667471
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of mammary tumorigenesis in nulliparous C3H mice by chronic feeding of the synthetic retinoid, N-(4-hydroxyphenyl)-retinamide.
Welsch CW; DeHoog JV; Moon RC
Carcinogenesis; 1983 Sep; 4(9):1185-7. PubMed ID: 6224605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
